| Literature DB >> 25824856 |
Maïté Fransolet, Laurie Henry, Soraya Labied, Marie-Caroline Masereel, Silvia Blacher, Agnès Noël, Jean-Michel Foidart, Michelle Nisolle, Carine Munaut.
Abstract
BACKGROUND: For women facing gonadotoxic treatment, cryopreservation of ovarian tissue with subsequent retransplantation during remission is a promising technique for fertility preservation. However, follicle loss within grafted ovarian tissue can be caused by ischemia and progressive revascularization. Several xenograft models using different immunodeficient rodent lines are suitable for studying ovarian tissue survival and follicular viability after frozen-thawed ovarian cortex transplantation. SCID mice, which are deficient for functional B and T cells, are the most commonly used mice for ovarian xenograft studies. However, due to incomplete immunosuppression, NOD-SCID mice displaying low NK cell function and an absence of circulating complement might be more appropriate. The present study aims to define the most appropriate immunodeficient mouse strain for ovarian tissue xenotransplantation by comparing ovarian graft recovery in SCID and NOD-SCID mice following engraftment in the presence of isoform 111 of vascular endothelial growth factor.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25824856 PMCID: PMC4377049 DOI: 10.1186/s13048-015-0142-6
Source DB: PubMed Journal: J Ovarian Res ISSN: 1757-2215 Impact factor: 4.234
Figure 1Histological analysis of haematoxylin and eosin sections of ovarian tissue. Representative illustrations of fresh ovarian tissue before cryopreservation (the cortex and medulla are identified by a plain and dotted arrow, respectively) (A); ovarian control grafts 3 days after transplantation in SCID mice (B) and NOD-SCID mice (C); ovarian control grafts 3 weeks after transplantation in SCID mice (D) and NOD-SCID mice (E). ► Indicates vessels. Scale bar: 500 μM. Images are representative of at least 2 experiments.
Figure 2Functional vascular network identification in ovarian tissue 3 days after transplantation in SCID and NOD-SCID mice. Representative illustrations of functional blood vessels (identified by plain arrows) revealed by dextran-FITC immunostaining in VEGF111 treated fragments grafted in SCID (A) and NOD-SCID (B) mice. Scale bar: 500 μM. Images are representative of at least 2 experiments.
Percentage of ovarian transplants positive for dextran/FITC staining 3 days after transplantation in SCID and NOD-SCID mice
|
|
| |
|---|---|---|
|
| Negative | Positive |
| CT (n = 21) | 13 (62) | 8 (38) |
| VEGF111 (n = 19) | 8 (42) | 11 (58) |
|
| Negative | Positive |
| CT (n = 8) | 2 (25) | 6 (75) |
| VEGF111 (n = 6) | 3 (50) | 3 (50) |
Figure 3Functional vascular network analysis of ovarian tissue 3 days after transplantation in SCID and NOD-SCID mice. Quantification of functional vessel density in ovarian transplants with or without VEGF111 treatment grafted in SCID or NOD-SCID mice. *p < 0.05.
Figure 4Follicle analysis of ovarian tissue 3 weeks after transplantation in SCID and NOD-SCID mice. H&E sections of fresh ovarian tissue (A) and ovarian control tissue transplanted in SCID (B) and NOD-SCID (C) mice (primordial and primary follicles are identified by plain and dotted arrows, respectively). Quantification of primordial (D) and primary (E) follicle density in ovarian transplants with or without VEGF111 treatment and grafted in SCID or NOD-SCID mice. Scale bar: 100 μM. Images are representative of at least 2 experiments.
Figure 5Fibrosis analysis of ovarian tissue 3 weeks after transplantation in SCID and NOD-SCID mice. Percentage of fibrotic tissue in fresh and frozen-thawed (F-T) ovarian biopsies and ovarian transplants grafted in SCID and NOD-SCID mice. ***p < 0.001.